This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bioventures, LLC. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Yonghan He: Innovator in Cancer Treatment
Introduction
Yonghan He is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic compounds.
Latest Patents
Yonghan He holds a patent for "BCL-2 proteins degraders for cancer treatment." This patent presents compositions and methods for selectively killing cancer cells. The composition comprises a compound of Formula (I). The selective killing of cancer cells occurs with an improved potency and safety profile compared to similar compounds. In particular, the compositions and methods of the invention show reduced platelet toxicity while retaining or improving toxicity in cancer cells. He has 1 patent to his name.
Career Highlights
Yonghan He is currently associated with Bioventures, LLC, where he continues to work on groundbreaking research in cancer therapeutics. His work focuses on developing safer and more effective treatments for cancer patients.
Collaborations
Some of his notable coworkers include Peiyi Zhang and Sajid Khan, who contribute to the collaborative efforts in advancing cancer treatment research.
Conclusion
Yonghan He is a dedicated inventor whose work in cancer treatment is paving the way for innovative therapies. His contributions are vital in the ongoing fight against cancer, showcasing the importance of research and development in medical science.